FDA seafood origin labeling is receiving greater attention as regulators clarify when voluntary domestic origin claims may be considered truthful and not misleading. Seafood importers, processors, distributors, and brand owners should examine both the wording of these claims and the supply chain evidence used to support them.
What the Draft Guidance Means for Seafood Businesses
Voluntary Claims Still Create Compliance Obligations
The FDA draft guidance addresses U.S.-origin statements for single-ingredient seafood and seafood components used in multi-ingredient foods. Potential statements include "U.S.-Caught," "U.S. Farm-Raised," "USA Seafood," and "Made with U.S. Seafood." American flag graphics and similar visual elements can also communicate an origin claim, even when the label contains no explicit origin sentence.
These statements remain voluntary. A company is not generally required by the FDA guidance to add a domestic origin claim simply because a product has a connection to the United States. Once a business chooses to make such a claim, however, it should be prepared to demonstrate that the statement is accurate and not misleading when the complete label is considered.
That full-label context is important. A narrowly accurate statement can still create compliance risk if graphics, product names, qualifying language, or placement cause consumers to draw a broader conclusion. For example, a claim concerning one seafood ingredient in a prepared food should not imply that every ingredient, processing step, or component is of U.S. origin.
The guidance remains in draft form and is nonbinding. It represents the FDA's current approach to claims that may satisfy federal food labeling expectations, but it does not independently create a mandatory domestic labeling program. It also does not cover state or local origin claims, and USDA-regulated catfish falls outside its scope.
Companies evaluating the draft may consider submitting comments under Docket FDA-2026-D-6729. Because public postings can identify different dates for particular stages of review, businesses should confirm the applicable submission deadline directly in the active docket before filing.
FDA Labeling and CBP Marking Are Separate Requirements
One Product Can Face Two Different Origin Analyses
The FDA guidance does not modify U.S. Customs and Border Protection country of origin marking rules. This distinction is critical for seafood importers because an FDA-compliant marketing claim does not necessarily resolve whether an imported product is properly marked for customs purposes.
CBP marking analysis generally focuses on the country of origin of imported merchandise and whether processing in another country results in a legally significant change. FDA labeling analysis focuses on whether food labeling is truthful and not misleading. The agencies therefore evaluate different legal questions, even when both questions involve the word "origin."
A seafood product may involve harvesting in one country, primary processing in another, packaging in the United States, and incorporation into a prepared food at a separate facility. The relevant facts may include where the seafood was caught or farm-raised, where it was headed, filleted, frozen, cooked, or canned, and how those activities affect the particular claim being made. A U.S. flag or "USA Seafood" statement could communicate more than the company intends if imported inputs or foreign processing are not clearly addressed.
Compliance teams should avoid using a CBP origin conclusion as the sole basis for FDA claim approval. They should also avoid assuming that FDA guidance authorizes a customs marking practice. The two analyses should be documented separately and then reviewed together for consistency across retail packaging, master cartons, shipping records, entry documentation, websites, and promotional materials.
When different teams control customs declarations and consumer labels, governance becomes especially important. Trade compliance, regulatory affairs, procurement, quality assurance, and marketing should agree on approved terminology. A centralized review process can prevent a marketing claim from contradicting supplier records or an origin declaration used during import entry.
Building a Defensible Seafood Labeling Program
Audit Claims, Evidence, and Supplier Controls
A practical response begins with an inventory of every domestic origin representation. The review should cover direct statements, flag graphics, maps, brand imagery, abbreviations, product descriptions, online listings, case labels, and claims made for seafood components in multi-ingredient foods. Businesses should include labels that use phrases such as "caught in America," "American seafood," or similar language, not only claims containing the formal term "U.S.-origin."
Each claim should then be mapped to supporting supply chain records. Depending on the product, substantiation may include vessel records, harvest certificates, aquaculture records, supplier declarations, bills of lading, production records, lot codes, purchase orders, transformation records, and inventory movement data. Records should connect the claim to identifiable lots rather than merely establish that a supplier sometimes handles domestic seafood.
Control Mixed-Origin and Multi-Ingredient Products
Blended inventories create particular risk. A processor that handles domestic and imported seafood should have controls capable of preserving identity, tracking substitutions, and preventing unsupported claims when supply changes. Contract language should require suppliers to notify the buyer when origin, processing location, species, or sourcing practices change.
Multi-ingredient foods require an additional level of precision. A statement such as "Made with U.S. Seafood" may describe the seafood component without describing sauces, seasonings, breading, oils, or other ingredients. Label design should make the scope of the statement clear and avoid creating the impression that the entire finished food is domestic.
Relabeling can also create significant cost. The FDA's planning estimate assumes approximately 1,150 manufacturers, packers, and distributors could revise five labels each, at an estimated $1,333 per label. That produces an estimated one-time industry cost of $7,664,750. These figures are planning assumptions rather than regulatory fees, but they illustrate why companies should coordinate legal review, artwork changes, inventory depletion, and packaging procurement before implementation.
- FDA issued draft guidance on October 23, 2026 (Federal Register notice of availability published October 27, 2026) providing examples of voluntary U.S.-origin statements (such as “U.S.-Caught,” “U.S. Farm-Raised,” “USA Seafood,” and “Made with U.S. Seafood”) plus American flag graphics that it would consider truthful and not misleading for single-ingredient seafood and seafood components of multi-ingredient foods.* The nonbinding guidance (Docket FDA-2026-D-6729) requires substantiation, does not cover state/local claims or USDA-regulated catfish, and notes statements must not be misleading in context of the full labeling. Comments are requested by December 28, 2026 (FDA site) or December 13, 2026 for consideration in the final version (HHS).
- The draft is part of the Trump Administration’s America First Seafood Strategy, announced the same day with the launch of Seafood.gov, more than $5 billion in USDA-guaranteed loans for meat and seafood processing, and FDA import alerts on 11 foreign firms after finding 46% of sampled imported frozen seafood used ice glaze to inflate net weight (up to 32.8% overage). HHS Secretary Robert F. Kennedy Jr. and Acting FDA Commissioner Kyle Diamantas framed it as helping consumers identify U.S. product and supporting domestic fishermen.
- New England Fishermen’s Stewardship Association called the voluntary “U.S. Caught Seafood” label a “major win” for domestic industry. On X, discussions (mostly October 23-26, 2026) mixed support for “Buy American” with notes that it addresses origin rather than safety/contaminants and a poll asking whether U.S.-caught seafood processed abroad should qualify.
- No later regulatory changes, finalized guidance, or significant new comments/industry analyses appeared in searches covering the subsequent days. The guidance remains draft/not for implementation.
Frequently Asked Questions
Are U.S.-Origin Statements Required on Seafood Labels?
No. The FDA guidance addresses voluntary U.S.-origin statements rather than imposing a general requirement to add them. Businesses choosing to use domestic origin language or imagery should typically maintain evidence showing that the representation is truthful and not misleading in the context of the complete label.
Does the Guidance Apply to Imported Seafood?
It can affect businesses handling imported seafood when labels combine imported and domestic inputs or otherwise suggest a U.S. connection. Importers and processors should evaluate harvesting, farming, processing, packaging, and ingredient facts before approving a claim. The exact analysis will generally depend on the claim's wording and the product's supply chain.
Does FDA Approval Resolve CBP Country of Origin Marking?
No. FDA food labeling expectations and CBP country of origin marking requirements are separate compliance frameworks. A company should perform both analyses where applicable. Documentation should also be checked for consistency so that the consumer label, customs entry, shipping carton, and supplier declaration do not present conflicting origin information.
What Records Should Support a U.S.-Origin Seafood Claim?
Appropriate records may include catch documentation, aquaculture records, supplier certifications, invoices, production records, lot-tracing data, bills of lading, and inventory controls. The evidence should support the specific representation being made and should remain connected to the relevant product lots throughout processing and distribution.
Does the Draft Cover Multi-Ingredient Foods?
Yes, it addresses seafood components in multi-ingredient foods. The claim should clearly communicate what is of U.S. origin and should not imply that unrelated ingredients or the entire finished product are domestic. Regulatory teams should review the statement together with graphics, placement, product naming, and qualifying language.
How Stable Software Can Help
Connect Trade Data With Duty Recovery Workflows
Seafood importers reviewing origin records may also identify imported merchandise that is later exported or destroyed under circumstances that could support duty drawback. Stable Software's DrawbackAI platform helps U.S. customs brokers provide white-labeled duty drawback software to importer clients and file claims under the broker's own filer code. Stable Software charges a flat software license and never takes a percentage of the refund. The platform does not replace FDA labeling analysis, but it can support a broader trade data strategy in which importers and brokers use organized transaction records to evaluate eligible drawback opportunities. Brokers serving seafood importers can explore whether DrawbackAI fits their client service model.
Resources
| Type | Resource |
|---|---|
| Source | Primary source |
